Indi-I think the big problem is that UNI is running behind the curve in getting a product completed and ready for trials. Many other companies have come into the party and are competing for the business with fully developed products. Even if UNI has a better mousetrap, the Pharmas may not be willing to wait another year or two or three. They will take what's available to get their drugs to market.
The money involved in these new drugs is so large that a few months delay to market can cost a Pharma 100's of millions in sales and profits. No device is worth waiting for and losing those profits.
- Forums
- ASX - By Stock
- UNS
- Wearable Injectors
Wearable Injectors, page-11
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online